Mike Laffan

33PUBLICATIONS
100CO-AUTHORS
Aircraft performance and flight control systemsAutoimmunityHaematologyHumoural immunology and immunochemistryApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Apr 10, 2026
TFPIα inhibition by andexanet alfa is partially restored by protein S and factor V-short.

Christina Keshini Crossette-Thambiah, Krister Bamberg, Mike A Laffan

|Feb 20, 2026
Anticoagulation, recurrent thrombosis, and major bleeding in antiphospholipid syndrome: UK multicenter observational study.

Christina Keshini Crossette-Thambiah, Indika Rajakaruna, Zain Odho

|Jan 26, 2026
Von Willebrand factor deficiency impairs angiogenesis via angiopoietin-2: relevance for gut angiodysplasia.

Adela Constantinescu-Bercu, Koval E Smith, Shuo Yi Wong

|Nov 17, 2025
Laboratory practice on detection of antiphospholipid antibodies: UK NEQAS blood coagulation survey-2024.

Deepa J Arachchillage, Mike Laffan, Will Lester

|Jul 01, 2025
Anti-PF4 disorders: Pathogenesis, diagnosis and treatment.

Megan V Preece, Devi V Pathak, Mike Laffan

|Feb 06, 2024
Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment.

Emily Symington, Savita Rangarajan, Will Lester

Pageof 6